When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Adalimumab - Wikipedia

   en.wikipedia.org/wiki/Adalimumab

   The best-selling drugs list published by Genetic Engineering & Biotechnology News, shows that Humira occupied the #1 position for 2015 (US$14.012 billion) and 2016 (US$16.078 billion) [99] From 2012 until the US patent expired in 2016, Humira led the list of top-selling pharmaceutical products, and in 2016, it had US$16 billion of global sales ...

3. Disease-modifying antirheumatic drug - Wikipedia

   en.wikipedia.org/wiki/Disease-modifying_anti...

   Although the use of the term DMARDs was first propagated in rheumatoid arthritis (hence their name), the term has come to pertain to many other diseases, such as Crohn's disease, lupus erythematosus, Sjögren syndrome, immune thrombocytopenic purpura, myasthenia gravis, sarcoidosis, and various others. [citation needed]

4. Cambridge Antibody Technology - Wikipedia

   en.wikipedia.org/wiki/Cambridge_Antibody_Technology

   Whilst for 2017, Abbvie reports that Humira achieved $18.427billion of sales in 2017 [84] Briakinumab (ABT-874) – a human monoclonal antibody to IL-12 and IL-23. This went on to be developed by Abbott Laboratories for treatment of psoriasis [85] and Crohn's disease. On 11 October 2010, Abbott presented positive Phase III data. [86]

5. Management of Crohn's disease - Wikipedia

   en.wikipedia.org/wiki/Management_of_Crohn's_disease

   Surgery is normally reserved for complications of Crohn's disease or when disease that resists treatment with drugs is confined to one location that can be removed. [30] Surgery is often used to manage complications of Crohn's disease, including fistulae , small bowel obstruction , colon cancer , small intestine cancer and fibrostenotic ...

6. UnitedHealth to remove AbbVie's Humira from some US drug ...

   www.aol.com/news/unitedhealth-remove-abbvies...

   The U.S. market share for Humira biosimilars stands at nearly 20%, compared with 2.2% in the first quarter of this year, Barclays analysts said in a note on Monday.

7. FDA-approved drug for ulcerative colitis also effective for ...

   www.aol.com/fda-approved-drug-ulcerative-colitis...

   Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, also sends Crohn's disease into clinical remission, new findings suggest.